Source: Bloomberg Economics
Summary
The US has initiated a tariff investigation against Germany, citing underpayment for innovative pharmaceuticals. This move could lead to potential tariffs on German goods as a form of economic retaliation.
Why It Matters
This investigation highlights ongoing tensions in international trade, particularly concerning pharmaceutical pricing practices. The outcome could significantly impact US-German trade relations, affecting both economies and the global pharmaceutical market.





